These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38142841)

  • 41. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ludwig MD; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis.
    Volpi C; Orabona C; Macchiarulo A; Bianchi R; Puccetti P; Grohmann U
    Expert Opin Drug Discov; 2019 Nov; 14(11):1199-1212. PubMed ID: 31389262
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.
    Sontag CJ; Nguyen HX; Kamei N; Uchida N; Anderson AJ; Cummings BJ
    Stem Cells Transl Med; 2013 Oct; 2(10):731-44. PubMed ID: 23981724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.
    Ambrosius B; Pitarokoili K; Schrewe L; Pedreiturria X; Motte J; Gold R
    J Neuroinflammation; 2017 Apr; 14(1):92. PubMed ID: 28446186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease modifying mitochondrial uncouplers, MP101, and a slow release ProDrug, MP201, in models of Multiple Sclerosis.
    Bando Y; Geisler JG
    Neurochem Int; 2019 Dec; 131():104561. PubMed ID: 31585135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
    Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D
    Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune Encephalomyelitis.
    Weier A; Enders M; Kirchner P; Ekici A; Bigaud M; Kapitza C; Wörl J; Kuerten S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Rapamycin on MOG-Reactive Immune Cells and Lipopolysaccharide-Activated Microglia: An
    Borim PA; Mimura LAN; Zorzella-Pezavento SFG; Polonio CM; Peron JPS; Sartori A; Fraga-Silva TFC
    J Interferon Cytokine Res; 2022 Apr; 42(4):153-160. PubMed ID: 35384725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
    de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ
    Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.
    Yang MT; Lin YC; Ho WH; Liu CL; Lee WT
    J Neuroinflammation; 2017 Jan; 14(1):15. PubMed ID: 28109197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Herrmann MM; Barth S; Greve B; Schumann KM; Bartels A; Weissert R
    Dis Model Mech; 2016 Oct; 9(10):1211-1220. PubMed ID: 27519689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of mTOR inhibitors in adult solid organ transplantation.
    Ventura-Aguiar P; Campistol JM; Diekmann F
    Expert Opin Drug Saf; 2016; 15(3):303-19. PubMed ID: 26667069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.
    Weichhart T; Haidinger M; Katholnig K; Kopecky C; Poglitsch M; Lassnig C; Rosner M; Zlabinger GJ; Hengstschläger M; Müller M; Hörl WH; Säemann MD
    Blood; 2011 Apr; 117(16):4273-83. PubMed ID: 21368289
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Lima C; Maleski ALA; Bernardo JTG; Zelli VC; Komegae EN; Lopes-Ferreira M
    Front Immunol; 2022; 13():857692. PubMed ID: 35401524
    [No Abstract]   [Full Text] [Related]  

  • 57. Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
    Koda T; Namba A; Nakatsuji Y; Niino M; Miyazaki Y; Sugimoto T; Kinoshita M; Takata K; Yamashita K; Shimizu M; Fukazawa T; Kumanogoh A; Mochizuki H; Okuno T
    PLoS One; 2018; 13(3):e0193986. PubMed ID: 29518148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.
    Martín-Montañez E; Pavia J; Valverde N; Boraldi F; Lara E; Oliver B; Hurtado-Guerrero I; Fernandez O; Garcia-Fernandez M
    Free Radic Biol Med; 2019 Jun; 137():116-130. PubMed ID: 31035004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells.
    Silic-Benussi M; Sharova E; Ciccarese F; Cavallari I; Raimondi V; Urso L; Corradin A; Kotler H; Scattolin G; Buldini B; Francescato S; Basso G; Minuzzo SA; Indraccolo S; D'Agostino DM; Ciminale V
    Redox Biol; 2022 May; 51():102268. PubMed ID: 35248829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.
    Malone K; Diaz Diaz AC; Shearer JA; Moore AC; Waeber C
    J Neuroinflammation; 2021 Jan; 18(1):37. PubMed ID: 33516262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.